I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolo..:
Juan Pablo Muñoz
;
Cristina Larrosa
;
Saray Chamorro
...
https://www.mdpi.com/2072-6694/15/19/4837. , 2023
Link:
https://doi.org/10.3390/cancers15194837
RT Journal T1
Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:7fff76c03b354eaeb358fd5a46df1428&Exemplar=1&LAN=DE A1 Juan Pablo Muñoz A1 Cristina Larrosa A1 Saray Chamorro A1 Sara Perez-Jaume A1 Margarida Simao A1 Nazaret Sanchez-Sierra A1 Amalia Varo A1 Maite Gorostegui A1 Alicia Castañeda A1 Moira Garraus A1 Sandra Lopez-Miralles A1 Jaume Mora PB MDPI AG YR 2023 K1 monoclonal antibody K1 disialoganglioside K1 anti-GD2 immunotherapy K1 childhood cancer K1 high-risk neuroblastoma K1 naxitamab K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/15/19/4837 LK http://dx.doi.org/https://doi.org/10.3390/cancers15194837 DO https://doi.org/10.3390/cancers15194837 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)